Business Novo Nordisk CEO Concedes Eli Lilly’s Market-Share Gains as Stock Slumps Last updated: August 13, 2026 5:31 am By admin Share 0 Min Read SHARE Novo Nordisk’s CEO conceded Eli Lilly is gaining market share even as oral Wegovy hits record prescriptions and the stock keeps falling. The post Novo Nordisk CEO Concedes Eli Lilly’s Market-Share Gains as Stock Slumps appeared first on BeInCrypto… Share This Article Email Copy Link Print Previous Article Gold breaks six-month resistance as China, ETFs boost demand Next Article Anthropic in talks to acquire Decart for $6B to boost AI efficiency Leave a Comment Leave a Reply Cancel replyCommentNameEmailWebsite Turn on JavaScript to leave a comment. FacebookLikeXFollowInstagramFollowLinkedInFollowMediumFollowRSS FeedFollow Most Read Worldcoin Price Tumbles After $52.5M Funding Deal—Here’s What Happened Top Cryptos Other Than Bitcoin and Ethereum Poised to Benefit From the CLARITY Act Indonesia faces test of central bank independence after governor’s shock exit AI stock sell-off deepens as investors dump chipmakers Punjab National Bank gets nod to raise $1.5 billion through foreign currency bond programme US stock futures extend gains slightly after economic data FTX Repayments: Creditors to Receive Another $900 Million Ethena (ENA) Price Consolidates Near Key Resistance While Bulls Await Confirmation—Here’s What’s Next Bomb kills three and wounds 21 at central Moscow restaurant Argentina’s farm exports fall 28% in July to $2.92 billion